Galunisertib Combined With Capecitabine in Advanced CRC With PM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Galunisertib Combined With Capecitabine in Advanced CRC With PM — Stella

Recruiting

Back to Colorectal Cancer Metastatic trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Netherlands

Netherlands Cancer Institute, Amsterdam

Amsterdam UMC, Amsterdam

Key details

Phase

Early testing / Safety & dosing

Sponsor

The Netherlands Cancer Institute

Collaborators

Amsterdam UMC

Enrollment target

~31 participants

Started

July 2023

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov